AWM
GILD icon

Avaii Wealth Management’s Gilead Sciences GILD Stock Holding History

Avaii Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Buy
2,603
+588
+29% +$82.3K 0.13% 101
2025
Q4 		$247K Buy
+2,015
New +$245K 0.09% 133
2024
Q2 		– Sell
-42,366
Closed -$3.1M – 149
2024
Q1 		$3.1M Buy
42,366
+35,042
+478% +$2.69M 1.82% 16
2023
Q4 		$593K Buy
+7,324
New +$570K 0.39% 58

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Avaii Wealth Management's GILD Position: Q1 2026 in Review

Avaii Wealth Management increased its Gilead Sciences (GILD) stake by 29% in Q1 2026, buying an estimated $82.3K and bringing the position to 2,603 shares worth $363K. The position accounts for 0.13% of the portfolio, ranked #101.

Avaii Wealth Management first reported a position in GILD in Q4 2023 and has held it in 4 quarters since. The position peaked at $3.1M in Q1 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Avaii Wealth Management held 2,603 shares of Gilead Sciences worth $363K as of Q1 2026.
  • Avaii Wealth Management bought 588 Gilead Sciences shares in Q1 2026, an estimated $82.3K.
  • Gilead Sciences made up 0.13% of Avaii Wealth Management's portfolio in Q1 2026, its #101 holding.
  • Avaii Wealth Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 4 quarters since.
  • Avaii Wealth Management's Gilead Sciences position peaked at $3.1M in Q1 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Avaii Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.